Related Experiment Videos
Coronary flow analysis during autoperfusion angioplasty
M Ferrari1, G S Werner, F von zur Mühlen
1Department of Cardiology, Georg-August-University, Göttingen, Germany.
Coronary Artery Disease
|February 24, 1998
Summary
Autoperfusion balloons provide only 56% of normal coronary blood flow during angioplasty, insufficient for high-risk patients. Alternative active coronary or circulatory support devices are recommended for these patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Autoperfusion balloons aim to protect the myocardium during angioplasty by utilizing aortic pressure for distal perfusion.
- While effective in vitro, the in vivo distal blood flow provided by these devices remains largely unquantified.
- These devices are particularly recommended for high-risk patients susceptible to hemodynamic collapse during balloon inflation.
Purpose of the Study:
- To quantify distal coronary blood flow during percutaneous transluminal coronary angioplasty (PTCA) using autoperfusion balloons.
- To assess the adequacy of distal perfusion provided by autoperfusion balloons in vivo.
Main Methods:
- Coronary flow velocity was measured using Doppler guidewires in eight patients undergoing elective PTCA.
- Coronary blood flow was calculated by multiplying luminal area with average peak flow velocity.
- Coronary flow velocity reserve was assessed before and after angioplasty via intracoronary adenosine injection.
Main Results:
- Distal coronary blood flow during balloon inflation was 19 +/- 3.8 ml/min, representing 56% of pre-angioplasty flow (35 ml/min).
- Four patients experienced electrocardiographic changes, and three reported chest pain during balloon inflation.
- Coronary flow velocity reserve significantly increased post-angioplasty (1.3 to 2.2, P < 0.001).
Conclusions:
- Autoperfusion balloons deliver insufficient distal coronary blood flow during PTCA, especially in high-risk patients.
- The measured coronary blood flow during angioplasty was 56% of the pre-procedure baseline.
- For high-risk patients requiring adequate perfusion, active coronary or circulatory support devices are advised.